Skip to main content
. 2008 May;6(3):253–262. doi: 10.1370/afm.845

Figure 3.

Figure 3.

Subgroup and sensitivity analyses of nonergot dopamine agonists evaluating response to Clinical Global Impression-Improvement scale.

CI=confidence interval; DA = dopamine agonists; ITT = intention to treat; NEDA = nonergot dopamine agonist; RR = relative risk.

Note: The dashed vertical line represents the combined treatment effect for the original analysis.